Icon

Epipen and Epipen Jr. - (0.15, 0.3mg/Delivery; Intramuscular, Subcutaneous:)

Epinephrine Mylan
0.15, 0.3mg/Delivery; Intramuscular, Subcutaneous:
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
Less Than 5
Less Than 5
Used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances
Yes
****, ****** *** *********** ***** **** ** *** ****** ******* ******** ** *** **, **** *** **** ************ *********. ******* ***** ********* **** ** ***** ** ****. *********** ***** ***(*)(*) *** *** ************ *********. ********** *** ********* **** **** *** *********** ***** *** ***** ** ********** *** *** *****. *** ** ****** *** ******** ** ***** ** ** ****. ***** ****** *** **** ** ****** **** $*** ** **** ** ** ***** $*** ** $*** ** ****. ** ** * ******* ******* *** ***** **** *** ******* ***********.
Epipen and Epipen Jr. Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
**** ******* ******* ******* ******* *******
****** ******* ******* ******* ******* *******
*********** ****** ******* [***(*)*] ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ *** *** **, **** ******* ******** ******** ** *** **, ****
****** ** \ ** *** **, **** ******* **** ****** **** ********
*********** ****** [***(*)*]** \ ** *** **, **** ******* **** ****** **** ********
  1. **** ** ,**** : **** ******** ******** ******* **** ***** *** **** ** ****** *** ****** ** *,***,*** (**** **, ****) *** '*** (**** **, ****)
  2. *** **, **** : **** *** ******** ***** * **** ******* **** ** ****** '*** *** '*** (**** **, ****)
  3. **** *, **** : ****** ******** ******** ******* **** ***** *** **** ** ****** *** ****** ** *,***,*** *** '*** ** ***** ** **.
  4. *** **, **** : **** *** ******** ***** * **** ******* ****** ** ****** '*** *** '*** (**** **, ****)
  5. *** *, **** : *********** ******** ******** *** **** ***** *** *** ***(**(*) **** **** ** **** '*** ******.
  6. *** **,**** : **** *** ******** ***** * **** ******* *********** ** ******** ***** ** ********.
  7. *** *, **** : ********** *** ********* **** *********** ***** *** ***** ** ********* *** *** *****.
  8. *** *, **** : ********** *** ********* **** **** ***** *** ***** ** ********* *** *** *****
  9. *** **, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****
  10. *** **, **** : **** ******** ******* ****** (*.* **) ** **
  11. *** **, **** : **** ******** ******* ****** **(*.** **) ** **

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.